Cargando…
Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19
Autores principales: | Li, Xueting, Liu, Ying, Song, Juanjuan, Zhong, Jiuchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476560/ https://www.ncbi.nlm.nih.gov/pubmed/32923317 http://dx.doi.org/10.1016/j.apsb.2020.09.003 |
Ejemplares similares
-
Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2
por: Cai, Guoshuai, et al.
Publicado: (2020) -
Stroke increases the expression of ACE2, the SARS-CoV-2 binding receptor, in murine lungs
por: Singh, Vikramjeet, et al.
Publicado: (2021) -
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes
por: Maggi, Fabrizio, et al.
Publicado: (2021) -
Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021) -
ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
por: Lee, Ivan T., et al.
Publicado: (2020)